BullFrog AI Holdings (BFRG) Change in Accured Expenses (2022 - 2025)
BullFrog AI Holdings' (BFRG) quarterly Change in Accured Expenses came in at -$38512.0 in Q4 2025, up 89.41% on a YoY basis from -$20333.1 in Q4 2024, and down 118.04% quarter-over-quarter from $213461.0 in Q3 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRG) Change in Accured Expenses (2022 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Change in Accured Expenses for 4 consecutive years, with -$38512.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 89.41% year-over-year to -$38512.0; the trailing twelve-month figure through Dec 2025 stood at $336715.0 (up 371.18% YoY), and the FY2025 full-year result was $336715.0, up 371.18% from the prior year.
- Change in Accured Expenses declined to -$38512.0 in Q4 2025 per BFRG's latest filing, from $213461.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $412635.0 in Q1 2022 and bottomed at -$608229.0 in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$3561.1 across 4 years, with a median of -$37370.5 in 2022.
- The widest YoY moves for Change in Accured Expenses: up 435.69% in 2024, down 774.58% in 2024.
- Over 4 years, Change in Accured Expenses stood at -$36229.0 in 2022, then slipped by 14.72% to -$41563.0 in 2023, then slumped by 774.58% to -$363502.0 in 2024, then surged by 89.41% to -$38512.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$38512.0, $213461.0, and -$150872.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 852.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 338.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 222.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 492.70 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 11.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -49.70 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 68.82 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -38,512.00 |
| Sep 30, 2025 | 213,461.00 |
| Jun 30, 2025 | -150,872.00 |
| Mar 31, 2025 | 312,638.00 |
| Dec 31, 2024 | -363,502.00 |
| Sep 30, 2024 | 247,221.00 |
| Jun 30, 2024 | 85,603.00 |
| Mar 31, 2024 | 102,140.00 |
| Dec 31, 2023 | -41,563.00 |
| Sep 30, 2023 | -73,646.00 |
| Jun 30, 2023 | -114,990.00 |
| Mar 31, 2023 | -608,229.00 |
| Dec 31, 2022 | -36,229.00 |
| Sep 30, 2022 | 116,289.00 |
| Jun 30, 2022 | -119,422.00 |
| Mar 31, 2022 | 412,635.00 |